Episode 685
Ozempic Vs. Glucose Monitors (feat. Sharam Fouladgar-Mercer) #685
March 30, 202632m 50s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Yet more GLP1 news this week.
People regain on average 60% of their lost weight within a year of stopping GLP-1 drugs — and the regained weight may be disproportionately fat rather than muscle.
So are a tool that biohackers have known about for years - CGMs - the answer?
Sharam Fouladgar-Mercer is the co-founder of Signos, the first ever FDA-cleared glucose system for weight management.
Follow Sharam Fouladgar-Mercer on LinkedIn.